Results 161 to 170 of about 3,790 (190)

Intravenous labetalol for the treatment of hypertension after carotid endarterectomy

Journal of Cardiothoracic Anesthesia, 1989
Hypertension after carotid endarterectomy has a variable incidence ranging up to 56%. Blood pressure (BP) control is essential due to possible increased risk of morbidity from neurologic deficits or cardiovascular complications. This study evaluated intravenous labetalol for control of hypertension after carotid endarterectomy. Sixty ASA II-IV patients
M E, Goldberg, J L, Seltzer, S S, Azad, S N, Smullens, A T, Marr, G E, Larijani   +5 more
openaire   +2 more sources

Clinical Evaluation of Intravenous Labetalol for the Treatment of Hypertensive Urgency

American Journal of Hypertension, 1988
Antihypertensive medications currently used in the treatment of hypertensive urgencies are limited due to deleterious side effects or requirements for sophisticated monitoring techniques. Labetalol HCl (Trandate) is a unique adrenergic blocking agent that can smoothly lower blood pressure following bolus injection without increasing heart rate or ...
J, Huey, J P, Thomas, D R, Hendricks, A E, Wehmeyer, L J, Johns, P E, MacCosbe   +5 more
openaire   +2 more sources

Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies

The American Journal of Medicine, 1983
The antihypertensive effects of intravenous labetalol were evaluated in 59 patients with hypertensive crises or severe hypertension in need of rapid lowering of blood pressure in a multicenter study. Patients appearing with a supine diastolic blood pressure 125 mm Hg or greater, or a supine systolic blood pressure of more than 200 mm Hg received an ...
D J, Wilson, J D, Wallin, N D, Vlachakis, E D, Freis, D G, Vidt, E L, Michelson, H G, Langford, W, Flamenbaum, M P, Poland   +8 more
openaire   +2 more sources

Intravenous labetalol in the management of severe hypertension and hypertensive emergencies

American Heart Journal, 1984
The intravenous administration of labetalol, a combined alpha- and beta-adrenergic receptor blocking agent, reduced diastolic blood pressure by 30 mm Hg or more in 15 of 17 patients with severe hypertension (supine diastolic blood pressure greater than or equal to 125 mm Hg).
M D, Cressman, D G, Vidt, R W, Gifford, W S, Moore, D J, Wilson   +4 more
openaire   +2 more sources

Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease

The American Journal of Cardiology, 1982
Labetalol, an alpha and beta receptor blocking agent, was evaluated in 11 patients with documented coronary artery disease and stable angina. The mean dose of labetalol was 1.5 (range 1 to 2) mg/kg. Cardiovascular effects began within 1 minute after injection and were maximal within 10 minutes. Mean arterial pressure decreased from 105 +/- 13 to 81 +/-
R M, Gagnon, M, Morissette, S, Présant, D, Savard, J, Lemire   +4 more
openaire   +2 more sources

The response of plasma catecholamines to intravenous labetalol: A comparison with sodium nitroprusside

Clinical Pharmacology and Therapeutics, 1983
Changes in mean arterial pressure (MAP), heart rate (HR), and plasma concentrations of norepinephrine (NE) and epinephrine were measured in eight hypertensive patients in a supine position after stepwise infusion of incremental sodium nitroprusside doses and intravenous injection of cumulative labetalol doses.
M S, Lin, J L, McNay, A M, Shepherd, T K, Keeton   +3 more
openaire   +2 more sources

Attenuation of the hemodynamic responses to endotracheal intubation with preinduction intravenous labetalol

Journal of Clinical Anesthesia, 1989
Endotracheal intubation following anesthesia induction frequently produces hypertension and tachycardia. This study evaluated the efficacy of preinduction IV labetalol for attenuating the hemodynamic responses to intubation following thiopental and succinylcholine induction of anesthesia.
J B, Leslie, R W, Kalayjian, T M, McLoughlin, J R, Plachetka   +3 more
openaire   +2 more sources

COMPARISON OF LABETALOL, CLONIDINE AND DIAZOXIDE INTRAVENOUSLY ADMINISTERED IN SEVERE HYPERTENSION

Medical Journal of Australia, 1979
Diazoxide, clonidine and labetalol, administered intravenously in fixed doses, were used to treat 30 episodes of severe hypertension in 27 patients. Labetalol in a fixed dose of 100 mg proved ineffective treatment. Diazoxide 300 mg and clonidine 300 micrograms were comparable in effectiveness.
C K, Yeung, G W, Thomas, J A, Whitworth, P, Kincaid-Smith   +3 more
openaire   +2 more sources

Intravenous Labetalol in Acute Aortic Dissection-Reply

JAMA: The Journal of the American Medical Association, 1987
In Reply.— Dr Eisele's point is well taken; however, the package insert for labetalol states that 300 mg is the usual intravenous dosage required prior to starting oral therapy, rather than an absolute maximum. In addition, it states that the infusion may be adjusted as needed to maintain an adequate blood pressure response.
openaire   +1 more source

Intravenous Labetalol for Treatment of Postoperative Hypertension

Anesthesiology, 1987
J B, Leslie, R W, Kalayjian, M A, Sirgo, J R, Plachetka, W D, Watkins   +4 more
openaire   +2 more sources